Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. is creating the first objective test to diagnose brain injury in less than 30 minutes by a simple blood test. The company was founded in 2002 with the vision to commercialize in vitro diagnostic tests for the detection of brain injury and neurological diseases. Initially inspired by research conducted at the University of Florida and The Evelyn F. and William McKnight Brain Institute, Banyan Biomarkers has made significant progress in developing and clinically validating novel enzyme linked immunosorbent assays (ELISAs) for traumatic brain injury (TBI).
For more information, please visit our website using the link above.